Tuesday, December 1, 2015

Osage raises $100 million venture fund

Bala Cynwyd-based Osage Partners completed fund-raising for a fund partnered with universities and aimed at investing in promising start-ups emerging from their campuses.

Osage raises $100 million venture fund


Osage Partners, of Bala Cynwyd, has raised $100 million for a venture capital fund that has teamed up with eight universities and is focused on investing in start-ups that emerge from work being done on campus.

Called Osage University Partners I, the fund will invest in both early- and late-stage companies involved in a wide range of industries, such as therapeutics, medical diagnostics, advanced materials, cleantech and software.

Managing partner Marc Singer said the fund enables the universities to participate in venture-capital rounds they'd previously were unable to fund. Osage has signed contracts with the University of Pennsylvania and seven other institutions:

  • California Institute of Technology;
  • Columbia University;
  • Duke University;
  • University of California at Berkeley;
  • University of Florida;
  • University of Michigan;
  • Yale University.

Singer said the size of initial deals would be between $1 million and $2 million, but the fund would look to invest a total of $3 million to $5 million in a single company over time. In all, Osage University Partners is seeking to invest in 40 companies.

The fund has already invested in nine companies, including Avid Radiopharmaceuticals Inc., a life-sciences firm that had emerged from Penn and was acquired by Eli Lilly & Co. last November.

Inquirer Columnist
We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy:

Philly.com comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by Philly.com staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
comments powered by Disqus
About this blog
Mike Armstrong blogs about Philadelphia corporations and business-related topics. Contact him at 215-854-2980. Reach Mike at marmstrong@phillynews.com.

Mike Armstrong Inquirer Columnist
Also on Philly.com:
letter icon Newsletter